Centers for Medicare and Medicaid Services Data Linkages (Medicare & Medicare Health Outcomes Survey)

CMS和NIH/NCI在一个合作研究项目下交换数据，以通过两个阶段的过程支持和加强每个机构的任务。CMS和NIH/NCI在信息交换协议(CMS IEA编号2018-40)中概述了开展这一合作研究项目的条款、条件、保障措施和程序。 简而言之，此IAA与数据交换的第一阶段有关，根据该阶段，NIH/NCI接收Medicare登记和利用(索赔和遭遇)数据以及NIH/NCI监测流行病学和最终结果(SEER)癌症复发数据中的人员的Medicaid登记数据，这些数据也在CMS数据中找到。然后，NIH/NCI采用CMS提供的数据并将其与癌症登记数据合并，以创建SEER-CMS数据集：SEER-Medicare、SEER-Medicaid、SEER-Medicare Health Response Survey(SEER-MHOS)和SEER-Healthcare Provider and Systems(SEER-CAHPS)。SEER-CMS数据集在NIH/NCI系统记录编号09-25-0200下维护。因此，NIH/NCI通过要求请求者提交研究特定研究建议的正式申请程序，监督SEER-CMS数据集的数据发布，其中必须包括所请求数据的理由和数据存储和保护计划、NIH/NCI数据使用协议，以及机构审查委员会的评估文件。对SEER-CMS数据的分析使越来越多的美国人口能够深入了解从筛查到生命终结的整个癌症连续过程中的癌症护理服务和结果。 根据这项IAA，CMS将从慢性病仓库/虚拟研究数据中心(CCW/VRDC)向NIH/NCI提供所需的数据。提出请求的组织将遵守CMS的所有数据发布政策和程序。一旦满足所有CMS数据要求，CMS将向批准用户提供适当的最低限度必要的数据。

The CMS and the NIH/NCI exchange data under a cooperative research project to support and enhance each agency’s mission via a two phase process. The terms, conditions, safeguards, and procedures under which CMS and NIH/NCI conduct this cooperative research project are outlined in an Information Exchange Agreement (CMS IEA No. 2018-40). Briefly, this IAA is related to the first phase of the data exchange, whereby NIH/NCI receives Medicare enrollment and utilization (claims and encounter) data and Medicaid enrollment data for persons in the NIH/NCI Surveillance Epidemiolgy and End Results (SEER) cancer regristry data who are also found in the CMS data. NIH/NCI then takes the data provided by CMS and merges it with the cancer registry data to create the SEER-CMS datasets: SEER-Medicare, SEER-Medicaid, SEER-Medicare Health Outcomes Survey (SEER-MHOS), and SEER-Consumer Assessment of Healthcare Providers and Systems (SEER-CAHPS). The SEER-CMS datasets are maintained under the NIH/NCI System of Record No. 09-25-0200. Thereby, NIH/NCI oversees the release of data from the SEER-CMS datasets through formal application processes that require requestors to submit research specific study proposals, which must include justification for the requested data and a data storage and protection plan, a NIH/NCI Data Use Agreement, and documentation of an Institutional Review Board assessment. The analyses of the SEER-CMS data allows for insights into cancer care delivery and outcomes across the cancer continuum from screening to end-of-life for a growing proportion of the US population. Under this IAA, CMS will provide NIH/NCI with the requested data from the Chronic Condition Warehous/Virtual Research Data Center (CCW/VRDC). The requesting organization will conform with all of CMS's data release policies and procedures. CMS will make the appropriate minimally necessary data available to approved users once all CMS data requirements are met.